Today: 1 July 2026
Palantir stock braces for Monday earnings after Friday drop as options price in a big swing
1 February 2026
2 mins read

Palantir stock braces for Monday earnings after Friday drop as options price in a big swing

New York, Feb 1, 2026, 11:37 EST — Market closed

  • Palantir shares fell 3.4% by Friday’s close, ahead of Monday’s after-hours earnings release.
  • Options markets are bracing for a sharp move in the week following earnings.
  • With a packed data week ahead, investors are zeroing in on guidance, particularly on commercial growth.

Palantir Technologies shares dropped 3.4% on Friday, closing at $146.59. U.S. markets remained closed on Sunday as investors gear up for the company’s upcoming quarterly report early next week.

This is crucial now since Palantir’s trading mirrors that of a high-conviction AI stock: it can brush off setbacks—until suddenly it can’t. Investors have shown they’re quick to slam expensive software names the moment guidance softens or growth misses the “better than expected” mark, even if it’s still solid.

Options — contracts allowing investors to hedge or speculate on price moves — suggest the stock could jump at least 9% by next week’s close, based on current pricing. Visible Alpha’s analysts forecast a record fourth-quarter revenue around $1.34 billion and adjusted earnings of $0.23 per share. Ratings are roughly evenly split between buy and hold.

Palantir announced via Nasdaq it plans to report its fourth-quarter and full-year earnings on Monday, Feb. 2, after the U.S. market closes. A webcast will follow at 5 p.m. ET.

The report will probably matter less for the headline numbers and more for management’s comments on the upcoming quarters. Traders are focused on how quickly the commercial side is growing, the costs involved in securing that business, and the performance of the more stable government segment.

Palantir competes in a packed field of data and AI software providers. When valuation questions arise, investors often compare its growth and margins to peers like Snowflake Inc. and C3.ai Inc.

At January’s World Economic Forum in Davos, CEO Alex Karp declared that “the demand for our product in America is greater than we can satisfy,” a statement investors will be watching closely for in upcoming guidance. Reuters

But the situation can backfire. Palantir proved that even a beat doesn’t guarantee a lift when expectations are sky-high: in May 2025, the stock plunged over 13% after quarterly results and an upgraded forecast fell short of impressing investors who had already pushed the shares up before the announcement.

A weaker-than-anticipated outlook might prolong the recent slide, with the options market pricing in that risk in real dollars. On the other hand, a more upbeat forecast would shift attention to how long Palantir can keep growing commercial revenue without sacrificing profitability.

Traders are zeroed in on one key macro event beyond individual company news: the U.S. Bureau of Labor Statistics will release the January jobs report on Friday, Feb. 6. This report frequently rattles interest-rate expectations and tends to impact the most rate-sensitive growth stocks.

Palantir’s next big moment comes Monday after the close, when it reports earnings and updates guidance. Then management will host a webcast. Investors will be tuned in, hunting for any shifts in growth outlook or changes that could impact the stock’s valuation case.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • AstraZeneca (AZN) Adds 14,784 Shares to LSE Listing
    July 1, 2026, 11:12 AM EDT. AstraZeneca PLC put 14,784 more ordinary shares onto the London Stock Exchange's Main Market, bringing its total to 1.55 billion. The new shares, each at $0.25, came through employee plans from June 1 to June 30, 2026, and match the old shares. Admission was done under The Public Offers and Admissions to Trading Regulations 2024. AstraZeneca used a block admission lodged January 29, 2021. The shares were issued for employee programs and didn't need a new prospectus. The stock trades under ISIN GB0009895292.
C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers
Previous Story

C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers

OCBC stock price drops in Singapore as metals rout jolts markets; earnings next
Next Story

OCBC stock price drops in Singapore as metals rout jolts markets; earnings next

Go toTop